mitoxantrone has been researched along with Uterine Neoplasms in 12 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-nine evaluable patients with metastatic or recurrent leiomyosarcoma or malignant mixed mesodermal tumors of the uterus were treated with mitoxantrone 12 mg/m2 every 3 weeks." | 5.06 | Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group. ( Adcock, L; Beecham, J; Bundy, BN; Muss, HB, 1990) |
| " As a functional consequence, knockdown of BCRP by siRNAs increased the sensitivity of human choriocarcinoma BeWo cells to mitoxantrone and topotecan by 10." | 3.72 | Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference. ( Beck, WT; Ee, PL; He, X; Ross, DD, 2004) |
| "35 ovarian cancer patients with ascites have been treated intraperitoneally with mitomycin C or mitoxantrone or interferon beta or tumor necrosis factor (TNF)." | 3.68 | [Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms]. ( Chronides, A; Diedrich, K; Krebs, D; Mallmann, P; Wagner, U; Werner, A, 1991) |
| "Mitoxantrone was administered to 12 patients with advanced or recurrent endometrial carcinoma of whom only 1 had received prior chemotherapy (chlorambucil)." | 1.27 | Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma. ( Boadle, DJ; Tattersall, MH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, P | 1 |
| Diao, W | 1 |
| Jiang, X | 1 |
| Chandacham, A | 1 |
| Kietpeerakool, C | 1 |
| Khunamornpong, S | 1 |
| Suprasert, P | 1 |
| Srisomboon, J | 1 |
| Charoenkwan, K | 1 |
| Phongnarisorn, C | 1 |
| Cheewakraingkrai, C | 1 |
| Siriaree, S | 1 |
| Tantipalakorn, C | 1 |
| Ee, PL | 1 |
| He, X | 1 |
| Ross, DD | 1 |
| Beck, WT | 1 |
| Görich, J | 1 |
| Brensing, KA | 1 |
| Kunze, V | 1 |
| Sokiranski, R | 1 |
| Rilinger, N | 1 |
| Müller-Miny, H | 1 |
| Brambs, HJ | 1 |
| Werner, A | 2 |
| Mallmann, P | 1 |
| Chronides, A | 1 |
| Diedrich, K | 2 |
| Wagner, U | 1 |
| Krebs, D | 2 |
| Veenhof, KH | 1 |
| George, M | 1 |
| Forni, M | 1 |
| Tumolo, S | 1 |
| Rotmensz, N | 1 |
| Vermorken, JB | 1 |
| Muss, HB | 2 |
| Bundy, BN | 2 |
| Adcock, L | 1 |
| Beecham, J | 1 |
| Runge, HM | 1 |
| Meerpohl, HG | 1 |
| Pfleiderer, A | 1 |
| Bode, U | 1 |
| Musch, E | 1 |
| Boadle, DJ | 1 |
| Tattersall, MH | 1 |
| DiSaia, PJ | 1 |
| Ehrlich, CE | 1 |
| Hilgers, RD | 1 |
| Von Hoff, DD | 1 |
| Stephens, RL | 1 |
| Boutselis, JG | 1 |
| Rivkin, SE | 1 |
1 trial available for mitoxantrone and Uterine Neoplasms
| Article | Year |
|---|---|
Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Leiomyosarcoma; Middle Aged; Mitoxantrone; Multicenter | 1990 |
11 other studies available for mitoxantrone and Uterine Neoplasms
| Article | Year |
|---|---|
A Successfully Treated Metastatic Choriocarcinoma Coexistent With Pregnancy: A Case Report of a 4-Year Follow-Up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Choriocarcinoma; Cyclophosp | 2016 |
Successfully conservative treatment of large cervical choriocarcinoma with profuse vaginal bleeding.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cytarabine; Diagnosis, Diffe | 2009 |
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette | 2004 |
[Percutaneous drainage of refractory necrotizing tumors: experience in 9 patients].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cystadenocarcinoma; Drainage; Female; His | 1995 |
[Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms].
Topics: Ascites; Breast Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Interferon- | 1991 |
Mitoxantrone in advanced and/or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Drug Evaluation; Female; Humans; Middle Aged; Mitoxantrone; Uterine Neoplasms | 1990 |
Mitoxantrone therapy of advanced adenocarcinoma of the endometrium. A phase II trial.
Topics: Adenocarcinoma; Aged; Drug Evaluation; Female; Follow-Up Studies; Humans; Middle Aged; Mitoxantrone; | 1989 |
[Tolerance of intraoperative, intraperitoneal chemotherapy in advanced gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female | 1988 |
Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Drug Evaluation; Female; Humans; Middle Aged; Mitoxantrone; Neoplasm Recurrenc | 1987 |
Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Uterin | 1987 |
Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Aged; Anthraquinones; Endometrium; Female; Humans; Middle Aged; Mitoxantrone; Uterin | 1985 |